Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method and application of amphiphilic prodrug and nanoparticle thereof for active targeted therapy of tumors

An active targeting, nanoparticle technology, applied in the preparation methods of peptides, anti-tumor drugs, pharmaceutical formulations, etc., can solve the problems of normal tissue or organ toxicity, weak targeting, poor selectivity, etc., and achieve good tumor targeting. Ability, Reduced Toxicity, Selective Effects

Active Publication Date: 2020-05-05
SHANGHAI JIAO TONG UNIV
View PDF13 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The first object of the present invention is to provide an amphiphilic prodrug and its nanoparticle for active tumor targeting therapy, so as to solve the high permeability and retention of nano antitumor drugs in the prior art only through solid tumors ( EPR) effect is enriched in tumor lesions, its targeting to cancer tissue or tumor cells is weak, and its selectivity is poor, and it will also cause toxicity, inflammation and other problems to normal tissues or organs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of amphiphilic prodrug and nanoparticle thereof for active targeted therapy of tumors
  • Preparation method and application of amphiphilic prodrug and nanoparticle thereof for active targeted therapy of tumors
  • Preparation method and application of amphiphilic prodrug and nanoparticle thereof for active targeted therapy of tumors

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032]

[0033] 1.1 Synthesis of Intermediate A-1

[0034] 3,3'-propane-2,2-diylbis(sulfadiyl)dipropionic acid (TK, 252.05mg), 1-ethyl-(3-dimethylaminopropyl)carbodiimide Add hydrochloride (EDCI, 287.55mg), 4-dimethylaminopyridine (DMAP, 12.2mg) and anhydrous triethylamine (TEA, 0.28mL) into the reaction flask, then add 25mL of anhydrous dichloromethane, and stir at room temperature After reacting for 1 hour, Epothilone B (507.27 mg) was added, followed by stirring and reacting at room temperature for 24 hours. After the reaction finishes, add 20mL deionized water for extraction, collect the organic phase, use dichloromethane and methanol volume ratio as (20:1) mixed solution as eluent, obtain white powdery intermediate A through column chromatography 1 (345.92 mg, 46.6% yield), MS m / z (ESI): 742.3039 [M+H] + . 1 H NMR (CDCl 3 ,400MHz)δ7.04(1H,s),6.82(1H,bs),5.34(1H,dd),5.26(1H,dd),4.21(1H,m),4.19(1H,bs),3.56(1H ,dq),2.93(4H,m),2.84(1H,dd),2.75(3H,s),2.69(4H,m),2.51(1H...

Embodiment 2

[0044] This example provides an experiment on the effect of amphiphilic prodrug nanoparticles used for active tumor targeting therapy on cancer cells.

[0045] The amphiphilic prodrug nanoparticles (Assembly of A) prepared in Example 1 and the bulk drug Epothilone B (Epothilone B) were formulated with cell culture medium to concentrations of 1.25, 2.5, 5, 10, 15 , 20, 40, and 80nmol / L solutions, and then respectively cultured with HCT116 cells (colon cancer cells) and PC-3 cells (prostate cancer cells) for 48 hours, using the MTT method for cell activity testing, the results are as follows Figure 4 shown. Epothilone B exhibited an efficient effect of killing cancer cells at a concentration of 2nmol / L; at the same time, when the concentration of amphiphilic prodrug nanoparticles reached 15nmol / L, it also showed a very good effect. The ability to kill cancer cells, and the killing effect of amphiphilic prodrug nanoparticles on cancer cells is proportional to the concentration....

Embodiment 3

[0047] Fluorescent imaging experiments of the amphiphilic prodrug nanoparticles used for active tumor targeting therapy in vivo in tumor-bearing nude mice.

[0048] Using Cy5.5 as the fluorescent probe molecule in vivo, Cy5.5 was encapsulated in the amphiphilic prodrug nanoparticles obtained in Example 1, and the targeting effect of the nanoparticles was evaluated. Digest PC-3 cells in the logarithmic growth phase, count, and prepare 4.0×10 6 cells / mL cell suspension, inoculated subcutaneously into the right anterior axillary of nude mice, each inoculated 200 μL, when the tumor grew to a volume of about 500mm 3 2 mice were randomly selected. 200 μL of Cy5.5-loaded nanoparticles were injected into PC-3 tumor-bearing mice through the tail vein. After 12 hours of injection, the ZKKS-Mulaurora imaging system was used to take pictures and analyze the fluorescence intensity of the whole body of the mice. The result is as Figure 5 shown. After the amphiphilic prodrug nanopartic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to View More

Abstract

A prodrug for active targeted therapy of tumors of the invention is an amphiphilic prodrug, containing a targeting head group, formed by coupling a small molecule linker with a hydrophobic antitumor drug and an active targeting hydrophilic short peptide, wherein the small molecule linker is a small molecule linker containing a thioketal bond. The amphiphilic prodrug containing the targeting head group can self-assemble in water to form a nanoparticle whose shell layer is the hydrophilic short peptide and whose inner core is the hydrophobic small molecule antitumor drug. Because the hydrophilicshort peptide on the surface of the nanoparticle can specifically bind to a receptor on tumor cells or tissues, the nanoparticle can actively target and enrich a tumor site to increase the concentration of the small molecule antitumor drug at the tumor site, the proliferation of tumor cells is effectively inhibited, at the same time, toxic and side effects of the anti-tumor drug on normal cells and tissues are reduced, and thereby the active targeted therapy of tumors is realized.

Description

technical field [0001] The invention relates to the technical field of nanomedicine, in particular to an amphiphilic prodrug for active tumor targeting therapy. Background technique [0002] Malignant tumor (cancer) is a major disease that seriously threatens human survival and social development, and has become a public health problem recognized all over the world. Therefore, how to effectively treat malignant tumors has become a difficult problem and a major challenge to be solved worldwide. At present, the treatment methods for malignant tumors mainly include the following types: surgical resection, chemotherapy, radiotherapy, immunotherapy and biological therapy. Among them, chemotherapy is one of the most effective treatments. However, most small-molecule anti-tumor drugs have disadvantages such as poor water solubility, large toxic and side effects on normal tissues of the body, and short half-life in vivo. In order to solve the above problems, the use of nano-sized...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/64A61K47/69A61K31/427A61K31/704A61K31/537A61P35/00C07K14/59C07K7/64C07K1/107C07K1/10
CPCA61K47/64A61K47/6929A61K31/427A61K31/704A61K31/537A61P35/00C07K14/59C07K7/64
Inventor 夏雪霖王冠春杨晓媛黄平黄卫颜德岳
Owner SHANGHAI JIAO TONG UNIV